<SEC-DOCUMENT>0001021561-14-000003.txt : 20140116
<SEC-HEADER>0001021561-14-000003.hdr.sgml : 20140116
<ACCEPTANCE-DATETIME>20140116132754
ACCESSION NUMBER:		0001021561-14-000003
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20131231
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20140116
DATE AS OF CHANGE:		20140116

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NU SKIN ENTERPRISES INC
		CENTRAL INDEX KEY:			0001021561
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				870565309
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12421
		FILM NUMBER:		14531552

	BUSINESS ADDRESS:	
		STREET 1:		75 WEST CENTER ST
		STREET 2:		ATTN: D. MATTHEW DORNY
		CITY:			PROVO
		STATE:			UT
		ZIP:			84601
		BUSINESS PHONE:		801-345-6100

	MAIL ADDRESS:	
		STREET 1:		75 WEST CENTER ST
		STREET 2:		ATTN: D. MATTHEW DORNY
		CITY:			PROVO
		STATE:			UT
		ZIP:			84601

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NU SKIN ASIA PACIFIC INC
		DATE OF NAME CHANGE:	19960919
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>release8k.htm
<DESCRIPTION>PRESS RELEASE DATED JANUARY 16, 2014 REGARDING CHINA
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: j
    Document created using Disclosure Solutions PROFILE 2.2.2.0
    Copyright 1995 - 2014 Thomson Reuters Accelus.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" bgcolor="#ffffff" text="#000000">
<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">UNITED STATES</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">SECURITIES AND EXCHANGE COMMISSION</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Washington, D.C. 20549</div>

<div><br>
</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">FORM 8-K</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">CURRENT REPORT</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>

<div><br>
</div>

<table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">
<div>&#160;</div>
</td>
<td style="WIDTH: 53.1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">January 16, 2014</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">
<div>&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">
<div>&#160;</div>
</td>
<td style="WIDTH: 53.1%; VERTICAL-ALIGN: top" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: center">Date of Report (Date of earliest event reported)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: center">&#160;</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">
<div>&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">
<div>&#160;</div>
</td>
<td style="WIDTH: 53.1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" colspan="3">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">NU SKIN ENTERPRISES, INC.</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">
<div>&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">
<div>&#160;</div>
</td>
<td style="WIDTH: 53.1%; VERTICAL-ALIGN: top" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: center">(Exact name of registrant as specified in its charter)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: center">&#160;</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">
<div>&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Delaware</div>
</td>
<td style="WIDTH: 12.92%; VERTICAL-ALIGN: bottom">
<div>&#160;</div>
</td>
<td style="WIDTH: 26.55%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">001-12421</div>
</td>
<td style="WIDTH: 13.63%; VERTICAL-ALIGN: bottom">
<div>&#160;</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">87-0565309</div>
</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: center">(State or other jurisdiction of incorporation)</div>
</td>
<td style="WIDTH: 12.92%; VERTICAL-ALIGN: top">
<div>&#160;</div>
</td>
<td style="WIDTH: 26.55%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: center">(Commission File Number)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: center">&#160;</div>
</td>
<td style="WIDTH: 13.63%; VERTICAL-ALIGN: top">
<div>&#160;</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: center">(IRS Employer Identification Number)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">
<div>&#160;</div>
</td>
<td style="WIDTH: 53.1%; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 2px solid" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">75 West Center Street</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Provo, UT 84601</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">
<div>&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">
<div>&#160;</div>
</td>
<td style="WIDTH: 53.1%; VERTICAL-ALIGN: top" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: center">(Address of principal executive offices and zip code)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: center">&#160;</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">
<div>&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">
<div>&#160;</div>
</td>
<td style="WIDTH: 53.1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">(801) 345-1000</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">
<div>&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">
<div>&#160;</div>
</td>
<td style="WIDTH: 53.1%; VERTICAL-ALIGN: top" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: center">(Registrant's telephone number, including area code)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: center">&#160;</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">
<div>&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">
<div>&#160;</div>
</td>
<td style="WIDTH: 53.1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">N/A</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">
<div>&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">
<div>&#160;</div>
</td>
<td style="WIDTH: 53.1%; VERTICAL-ALIGN: top" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: center">(Former name or former address, if changed since last report)</div>

<div>&#160;</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">
<div>&#160;</div>
</td>
</tr>
</table>

<div><br>
</div>

<div style="MARGIN-BOTTOM: 12pt; FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: left">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: left"><font style="FONT-SIZE: 14pt; FONT-FAMILY: ''Times New Roman'', Times, serif">&#9633;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 6pt">&#160;&#160;&#160;&#160;&#160; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: left"><font style="FONT-SIZE: 14pt; FONT-FAMILY: ''Times New Roman'', Times, serif">&#9633;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 6pt">&#160;&#160;&#160;&#160;&#160; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: left">
<table class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 14pt; FONT-FAMILY: ''Times New Roman'', Times, serif; WIDTH: 18pt; VERTICAL-ALIGN: top; align: right">&#9633;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td>
</tr>
</table>
</div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: left">
<table class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 14pt; FONT-FAMILY: ''Times New Roman'', Times, serif; WIDTH: 18pt; VERTICAL-ALIGN: top; align: right">&#9633;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))</td>
</tr>
</table>
</div>

<div style="MARGIN-BOTTOM: 12pt"><br>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<hr id="DSPFPageBreak" style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade="noshade">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left">Item 7.01 Regulation FD Disclosure.</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: left">On January 16, 2014, Nu Skin Enterprises, Inc. (the "Company") issued a press release regarding recent developments in Mainland China. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: left">The information in this Item 7.01 is being furnished, not filed, pursuant to Regulation FD. Accordingly, such information will not be incorporated by reference into any registration statement filed by the Company under the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated therein by reference. The furnishing of such information is not intended to, and does not, constitute a determination or admission by the Company as to the materiality of such information. Such information contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 that represent the Company's current expectations and beliefs. The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially from any forward-looking statements or views expressed therein. For a detailed discussion of&#160;these risks and uncertainties, please see the documents filed by the Company with the Securities and Exchange Commission. The forward-looking statements set forth the Company's beliefs as of the date that such information was first provided, and the Company assumes no duty to update the forward-looking statements to reflect any change except as required by law.</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Item 9.01. Financial Statements and Exhibits.</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: left">(d) Exhibits.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: left; TEXT-INDENT: 36pt">99.1 Press release issued by Nu Skin Enterprises, Inc. on January 16, 2014.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: left; TEXT-INDENT: 36pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: left; TEXT-INDENT: 36pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: left; TEXT-INDENT: 36pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: left; TEXT-INDENT: 36pt">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<hr id="DSPFPageBreak" style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade="noshade">
</div>

<div style="MARGIN-BOTTOM: 12pt; FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">SIGNATURE</div>

<div style="MARGIN-BOTTOM: 12pt; FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: left">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 216pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-WEIGHT: bold">NU SKIN ENTERPRISES, INC.</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif"><br>
</font> (Registrant)</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 216pt"><u>/s/ Ritch N. Wood</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 216pt">Ritch N. Wood<font style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif"><br>
</font> Chief Financial Officer</div>

<div><br>
</div>

<div><br>
</div>

<div style="MARGIN-BOTTOM: 12pt; FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: left">Date: &#160;January 16, 2014</div>

<div style="MARGIN-BOTTOM: 12pt"><br>
</div>

<div style="MARGIN-BOTTOM: 12pt"><br>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<hr id="DSPFPageBreak" style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade="noshade">
</div>

<div style="MARGIN-BOTTOM: 12pt; FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">EXHIBIT INDEX</div>

<div style="MARGIN-BOTTOM: 12pt"><br>
</div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif"><u>Exhibit No.</u></font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 5.02pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-WEIGHT: bold"><u>Exhibit Description</u></font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: left">
<table class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; WIDTH: 162pt; VERTICAL-ALIGN: top; align: right">99.1</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; WIDTH: auto; VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left">Nu Skin Enterprises' press release dated January 16, 2014.</td>
</tr>
</table>
</div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: left; MARGIN-LEFT: 216pt; TEXT-INDENT: -216pt"><br>
</div>

<div style="MARGIN-BOTTOM: 12pt"><br>
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>nselogo3.jpg
<TEXT>
begin 644 nselogo3.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``24DJ``@````$`!H!!0`!
M````/@```!L!!0`!````1@```"@!`P`!`````@```#$!`@`0````3@``````
M``!@`````0```&`````!````4&%I;G0N3D54('8U+C`P`/_;`$,``@$!`0$!
M`@$!`0("`@("!`,"`@("!00$`P0&!08&!@4&!@8'"0@&!PD'!@8("P@)"@H*
M"@H&"`L,"PH,"0H*"O_;`$,!`@("`@("!0,#!0H'!@<*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"O_``!$(`&D!
M8`,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/W\HHHH`****`"BH[JZM;&UDO;VYCAAAC+S32N%5%`R6)/``'))
MKY3_`&A?^"Q'[*GP6O9_#O@R[N_'>K095D\/,@LD<?PM=,=K#WB$@_6NO"8#
M&8^IR8>#D_+IZO9?,\_,<URW*:7M,754%YO5^BW?R1]845\`>%O^"C__``4A
M^/FW6_V<OV(]/_L>=LVMYK,-U-"Z^@N6EM8G/3D?ES6QXA_:H_X+->!81JGB
MK]B7PI=VJC,D.@PR7DS#V6VU&9L_\!->D^'L;"7).=.,NSG&_P!USQ(\8Y94
MI^TITZLH?S*E-Q];V/N>BO@[X8_\%R?`HUIO"G[1OP-UOPE>P2>5<W.G2?:E
MB?N98)%CEB`]!YC>W/'V3\)?C5\*/COX43QM\(/'FG:_IKD*T]C-EH6QG9*A
MP\3XP=CA6P1Q7'C<IS'+U>O3:7?=?>KH]++.(<FSAVPE92E_+M+_`,!=G^%C
MJ****\X]D****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`K"^)GQ*\$_![P'J?Q+^(
MNNQ:;HVD6QGOKN4$[5'```Y9F)"JH!+,0`"36[7Y0_\`!6+]J/QC^TQ\?8_V
M6O@]:W^J:/X7OS;R:=I,#SR:KJZ[EE8(@+.(@6B4`'#"5N0PQZ^2Y5/-L:J5
M[16LGV7^;Z??T/G>)L^I\/Y:Z]N:I)\L(]Y/]%N_NW:/._VX_P#@I'\6_P!K
M[7;CPEX=GN]`\#+-LL?#MM+B2^`;Y9+ME_UC$@$1@E$.,;B-Y^NO^"=O_!)_
MP=\.?#UA\8OVG/"T&K^*;N-;C3_#>H1![;2%(!7S8V&);CU#96,\`%AN'R+X
M*_X)8_\`!0H+9>-_#OP?FTN[MI4NM/>?Q%96UU%(A#(X5I@T;!@"-VT@C/'6
MO0;+]M#_`(*B_L-^(;6+]H?0=9U713/Y;VWB^T$\%R>K+#J$629,9QB1P."4
M(XK[_'THUL"L%D]:G&VZ4ES/RNK_`#;W[GY'E6(EALT>9\1X:K.]N64H/DCY
MM.RLOLI:+HF[6_6".-(D$42!54`*JC``]*6O*_V2?VN_A9^V%\-U\=_#RZ:W
MN[9EBUO0;J0&YTV8@X5P/O(V"4D'#`'HRLJ^DZ]KNB^%M#O/$OB/5(+'3]/M
M9+F^O;J4)%!"BEGD=CPJA022>@%?E];#U\/6=&I%J2=FNI^ZX;&87%X6.(HS
M4H-736UO^!U[=3R_]JO]BOX'?M=^%9-'^(_AR.'5HH2NE>);*,+>V3<XP_\`
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M(/#ZN=I7(7[3;[B2T#,0,$EHV(5B<JS_`$!7X6VO@_\`:S_X)Z?&/1/B9XD^
M'FK>&M3TR]S;3W<6^SOEZ2V_G1$Q2HZ95@KDX.1@X-?M-\#/C#X4^/\`\)-!
M^,/@J4G3]=L%N(XV;+0/DK)"V/XDD5T/NIKYSB/)J.7U(XC"N]&>UG=)]K]N
MW_`/M.#.),1FU&6#QT7'$4MTU9R7\UNC6TO5/K9=9535M?T/03:C6]7MK3[=
M=I:V?VF94\^=\E8ER?F<X.%')Q5NOF__`(*BB^/[/&F#3+M[>Y_X3.P^SSQN
M5:-]DVU@1R"#@Y'(Q7S!]R?2%%>,_LE_'[Q#X]M]1^#/QCMOL'Q$\'D0:Y:R
M8'VZ(8"7D?9E8%<E>,LK#"NHKV:@"EIWB3P[K&HWFD:1K]E=7>G.JZA:VUTC
MR6K-G:)%4DH3@X!QG!]*-.\2>'=8U&\TC2-?LKJ[TYU74+6VND>2U9L[1(JD
ME"<'`.,X/I7@/[(__)U_[0'_`&'-*_\`0;NC]D?_`).O_:`_[#FE?^@W=,#Z
M+JEK_B3P[X4TXZOXIU^RTVT5PINM0NDAC#'H-SD#)]*NU\Z?\%2?^34+O_L.
M67_H34@/HNBBO!?V^O'GB_1O!'AGX6>!_$#Z1>^/O%5MHLNK1L5:UMY&`<@@
M@@DL@)R/EWCC.:%J!Z+XC_:0^`'A#5VT#Q-\9_#-E>QMMEM;C6H0\39QAQN^
M0_7%=1H'B/P]XLTN/7/"VO66I64W^JO-/NDFB?Z.A(/YUYOX,_8F_9>\%^&8
M_#47P=T74ML06:_UJQ2ZN9F[N9)`2I)Y^3:!V`'%;7P:_9N^$WP"O]:O?A9H
M<VG1Z[+%)=VAO))8HS&&`\L.24!WL2,GL!@``/0#KM.\2>'=8U&\TC2-?LKJ
M[TYU74+6VND>2U9L[1(JDE"<'`.,X/I5VOG3]D?_`).O_:`_[#FE?^@W=7_C
M]\?O&_C/QNW[+W[+TJ3^*ITQXC\1@YM_#EN>&8L/^6V#C`Y4D`9<_*6`]KTS
MQ?X2UK5KK0-&\4:==WUB<7UE:WL<DUN<XPZ*24YXY`YJ32_$GAW6[R[T_1=?
MLKRXT^7RK^"UNDD>V?GY9%4DHW!X.#P:Y/X`_`'P1^SSX(7PCX1B>>XG?SM7
MU>Y&;C4;@_>ED;ZDX7.%![DDGRW]B[_DOGQZ_P"QX3_T*YH`^@--U[1-8NKV
MQTK5K>YFTZX%O?Q03!FMY2BOL<#[K;74X/9A5NOAC6_BM\3?@=^VU\3_`(K>
M&=-FU+PMIE]IT?C;3(&)86LL"*ERJ]-T;*?F[!R#A68C[8\+>*-`\:^'+'Q;
MX6U2*]T[4;9+BSNH3E9(V&0?;W!Y!X/-#0#]=\0Z!X7TU]9\3:Y9Z=9QD"2[
MO[E(8U).`"SD`9)P.:LP3P74"75K,DD4B!HY(V!5E(R"".H([UX+_P`%,_\`
MDT'7O^O^P_\`2F.O8?AC_P`DV\/?]@.T_P#1*4@-RBBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@#D?CWXZUGX;?!OQ%XQ\,61NM8MM->/0;-4#&YU&7$5I
M#@\'?.\2?\"KP?X$_#3]ES_@F'\)8/$7QQ^(>BV?C'7(3-XC\27[M->:A.Q#
MR16Z`-,\*,0,(OS$!V&3Q[Q\>O'7A/X7?![Q!\3O&U@+K3_#=@=5:V+[3++;
M,)H44]F,J1A3TW8S7YX_LO\`["_Q*_X*1>*[[]K[]KCQCJ-GH>KWC_V5IUA\
MDUY$C$!(2X86]JARBX#,^&.0?G;Z/*J-*IE]26(J.G1NN9K>;M[L5Z:M]-5Z
MKXOB#$UZ.<48X2BJV)<7R*7PTU?WYR]?=BK-/1J^MG]%7G_!:3]A^VO_`+'#
MKOB2XCW$?:H?#SB/`[X=E;!_W<^U>I_#C]I3]D#]M;PS?>!/"?C?0_%-O?6C
M+J/AK4X&BG>+'S9MIU5V53CYU!`."&Z&N6B_X)1_L"1Z:-,/P!A=1'M,S:]J
M'FGWWBXSG_/2ODK]NK_@EC>?LQZ(W[3'[)?BC68[3P](MYJ.EO=$W>EJIS]K
MMYUPS(G!93EE`+[B`0O30PW#6.JJEAYU*51_"Y6LWTVV^]'%B\9QOE5"6(QE
M*C7I)>]&',I*/7XE9JV^DON(9OAWJ_\`P2M_X*.^&)?"^JW/_"O/',ZVB&Y?
M?_H4TJQRPR'JS6TK1R!NI4)DDLP/K'_!:7XP>,;S2O!7[('PS,TNJ>.]1274
M+2V?$ES&)EBM;?W62<D_6!>Q->:?MC_%V3]KS_@EKX(_:(UTP)XK\->,(['5
M[F`;")MDL4A4#A3+_HLY`P!T'05[)\1O"2?$'_@M;X.?5X5GM_"_PV_M"&)T
M!`*M=JA.>ZRW`<'DY4=AQZS?^T4<9BE>K2C54O[TJ5N5_P#DR=SY^*7U/$9=
M@9-4,1.@X=XQKWYUY)<C5NU^IZA^S#^S9\`/^"=7P,&J^+->T73M2>U1O%GC
M+5)DA-S,1N,*.^"(@1A(EY;`."Y)/,^*/^"R7[#/AW5#IMCXTUK6%5PK76E^
M'YO*'J<S>62!Z@'/;-?)7B+0?C5_P5\_;,UO0K#Q/+I?@'PE=2Q6URT1>WTV
MR$AC1EC!`>ZN"A?DYP&YV1`#[#\!_P#!(;]A?P;H<>EZK\+[KQ#=*H$NIZUK
M=SYLIQ_=A>.->_W4'7OQ7G8O"Y7A9^TS6I.=:>KC&WNWV3;_`"6W:UF>SE^.
MSW'TG1R"C3I8:F^6,ZE_>MHVDN[ZM._5WNEH>#_VXOV!_P!LK2I_@[?>.-+O
M1K<?V>7PWXJL7M#<ECA50R@(\F<%1&Y<$`C!`--_8D^#^L_LF^.?&O[+CZG/
M>>%S-'XC\`7=TVZ3[).3%=6S'INAE2(G'7[0KX!?`\L_:B_X(J_!#QEX9NM=
M_9G\_P`)^(K>(O:Z9/?R7&GWC`$[&,K-)"S'`#ABJ_W.<C=_X)1_'CQC\3/#
MNL_!?X[6<X\??"IGTG[1J$C?:6L)I%#1R9/SO'):JC/SE5BYR26PKT<$\JJU
M,!4E*GIS0E;FB[^[)6TW]UVZ/[NG#8C,UGU"EFU*,:VO)4A?EG&WO0=];V]Y
M7MJEHKZ_85?.G_!3G_D@>C_]CQI__H,U?1=?.G_!3G_D@>C_`/8\:?\`^@S5
M\LMS[\W?VL_@/XJ\13Z=^T!\#<6OQ!\)#S+,QC_D*VHR7LY!_'D%MH/7<R\;
MLCM/V>/CQX6_:'^&UKX\\.9@G#>1J^F2']Y872@;XF'XY![J0>#D#NJ^9_CU
MX3\1?LG?%B3]K?X4Z1-=>'-5D6/XF>'+0??0GB_C7IO!)+=,,22<22$&X%W]
MD?\`Y.O_`&@/^PYI7_H-W1^R/_R=?^T!_P!AS2O_`$&[K/\`V'?%.@>-_P!H
MOXY>+_"NIQWNG:EJ6CW%E=1'Y9(V2[(//(/J#R#D'!%6/@#=1^"/V^/B_P"`
M]3G,,OB*TL-6TY)<8N41/F*G`SM,[#`_NMUVYH`^DZ^=/^"I/_)J%W_V'++_
M`-":OHNOFO\`X*;7\>M?"KPU\'M-E#ZOXO\`&%I;6%JHR[JI(9P/9WB'_`Q0
MMP/I2O.?VH?V?-._:/\`ADW@V36'TS4[.\2^T+5H@=UI=("%;@@E2&93@\9#
M#E17HU%(#YBT+]KWXS?L\-#X0_;0^%E\MM"ZP0^/_#T'GV5SS@/*J@;2<$G&
M'/\`SR%?1/@WQKX3^(?ANV\7^"/$%KJFF7B;K:\LY0Z/S@CV(.05.""""`15
MW4]+TS6M/FTC6=.@N[2YC,=Q:W4*R1RH1@JRL"&!]#7S)^RUH-K\'/VV?B7\
M"/`4LJ>$QH]MJT6G&8O'8W3B`[%R3MR)G]RJ(#G:#3W`\<\:_&_X@_"S]I+X
MM^#/`6I6^A-XR\7Z;I]WXSO@WD:*@6X&20I".X=B&/W1$Y`R-R_9?[/OP%\"
M?L_>!(_"W@Q3<S7)$^JZS/AI]2G(YE=N>.3M7.%![DDGQ7X$_#_PE\4OC]^T
M?X#\<:1'?:9J.JZ7%<02#I\MWAU/\+J<,K#D$`BD^'7Q%\;?L.>-K/X#_'C5
MYM1^'^HS>5X)\;3C_CQ]+2Y/10!T/11R/DR(V!]2U\Z?L7?\E\^/7_8\)_Z%
M<U]%1R1RQK+$X96`*LIR"#W%?.O[%W_)?/CU_P!CPG_H5S2`@_9_T^QU;]M3
MX\:7JEG%<6US#ID5Q;SQADEC:W8,K*>"""00>H-4/!NH7W[!OQE3X5^)+N5O
MA5XROF?PMJ=Q(630;YCEK61S]V-CR">.CYXE-:O[-_\`R?'\<?\`N$_^B37M
M'Q<^%7A#XU?#[4?AOXWL?.L=0AVEE^_!(.4E0]G5L$'\#D$B@#R;_@IG_P`F
M@Z]_U_V'_I3'7L/PQ_Y)MX>_[`=I_P"B4KX<_:'^)_C;P#^SGXH_8\^.EP\N
MOZ'+8R^%M:<'9K6F+<H$8$]711ZDX5@>8V)^T/#'C+POX,^%GAF[\3ZU#:+<
M:3:16R.27GD\A6V1HH+.V`3A03@$]`:'H!U]%4]`\0Z'XITJ+6_#FJP7MI-G
MRY[>0,I(.&4XZ,"""#R"""`15RD`4444`%%%%`!1110`4444`%%%%`!1110!
MX7_P4J\+:WXV_8E\;^%_#N[[7=QV"IM4$[1J%LS\$C^`-7RS_P`%&_\`@H#X
MD_9IN+#]C/\`91U*/1%\,Z-;6>M:W;Q*TUL!"HBM8"050B+:SR`;@S`*4*MG
M]$M5TK3=<TR?1M8LH[FUNHFBN()ERLB$8((^E?AI_P`%"]"UKP[^VS\2[#7H
MG2:7Q3/=1A\Y,,V)H3SV,;H1VQTXK[7A&CA\?6]A65U3YII/9M\L=5UM;\3\
MQ\0\1C,JH?6L-)QE54:;DM&E'GDTGTYN9?*)SVE_M=?M4:/K@\26'[1WCA;T
M/N:>3Q3=2;_9@TA#C@<,"*_3G_@F;^W!<_ML_#77?A-\;;6VN?$^D6.S4Y$A
M$<6LZ?,#&92BX"N"=D@4!?G0KC<0OY!5];?\$5-2O;']MNWM;6<HEYX7U"&Y
M4?QH!'(`?^!1H?PKZWB3+,)6RJI44$I07,FE9JW^9^?<&YWF&%SZC1=1RA5D
MHRBVVGS:7L^J>M_ELS0BLX]._P""-_B33XG++!\9S&K-U(6.$9/Y5]>_\YG?
M^Z,?^W5?)%W_`,H?O%?_`&6U_P#T"&OK?_G,[_W1C_VZKP,QU]M_W'_*D?5Y
M)MAO7"?G7.`_X)7>,/`'[,__``3H\6_M%>*X_P!U'KMY>:@T2@2S^4D,,%LI
M)P2TAVKG`#3'/K7Q?\?O^"B_[5_Q[\776NW?Q9UKP_IDDI^P^'_#FJ2VEM;1
M;LJC>45,S#N\F23TP,`>K76MWFE?\$2[:PM6(34_BD;:X`.,H-\P^OS1+7QK
M7OY5EV&J8W$XNK%2FZDDKZV2MM_6Q\GGN<XREEF"P%";A35*,FD[7E*[=[;K
MR[W9]'?LM_\`!3K]IG]GKQG:7?B3X@:OXO\`#32JNJ:#K^HO<EHL\F"64LT+
M@$D8.PG[RFOT.^"_AOPYJO\`P4(UCX]?#AQ+H'CSX+:;J\EQ&A599Y;L)$Y'
M3<T,"GGG.[/?/XQU^Y/_``3G\)WWAG]C'X=R:]:@:C<^%H&>9HP':V:2:>W0
M^RQS\?[Q]:\GB[#X7`T/;THJ,IW@[:73UN_2WXGT'A[BL=FF+^J5YN4*352+
M>O*U[MD^BDI;;:.V[/;Z\H_;$^!7B[]H/X8V'@OP9J.G6MU:^([74))-4FD2
M,Q1"0,`8T<[OF&!C'7D5ZO7+?%3QCXT\!^&;_P`6^'?">EZG::7I<]Y>+>ZY
M):28B1G*H%MI0V0IY)7G\Z_,S]P.IJ*_L;+5+&;3-2M([BVN(FBN()D#)(C#
M#*P/!!!((/7-<?:_$KQA9W?A>U\6>#--MO\`A*=7^Q6K:=KLESY*_P!GW=X7
M;?;1<_Z,$VC_`)Z%L_+AHOBO\9W^&=Q>VT7AD7[6GA2\UI=U]Y0<P2PQ^2?D
M;&[SL[^<;?NG/`!Q_P"RY^RG'^S-\2/']UX>ND?PYXD?3YM$A,A,MMY?VKS8
M6SU"F5=K<Y4C/(-7OVD_V6(OC3JVE?$CP1XTN?"OC?P\I&CZ_:)N#)DGR9EX
M+)DMCGC>V0P)4^A>'+_XBW5\\?B[PMHMC;"(E)=-U^:Z<OD84H]K$`N-QW;B
M<@#'.1Y'9?M(?M'>(KWQ7K_@/]G+1M=\/>%_$]]HK6]MXT:+5[QK63;)/%#)
M:"$Y`.(C,I).-WKT4</5Q%W"VEMVEOMNT<F*QV'P;BJE[RO9*,I/3?2*;T,V
M.]_X*<Z1;C0&TCX7ZJX4*NN/)<H3URS(&0;NAX0`>A[:OP<_91\8VWQ/3X_?
MM*_$./Q9XOMXC%I-O:0E-/TI",?N4(7+<M@[5QN+$%OF&9XI_P""@_A"TT"3
MQ?X#\%R:WI1^$NH^-K:XFU'[+(QM+N&V>P>/RG\MP\C!GR=K1%=K9S5_Q;^T
MO^T;\/OAA??%;QM^S5X<@T^"TM7LH['XDR3R7$UQ<P01QL#IJ"-?WQ8O\V-F
M-ISD=']F8[1.*3;LKN*=]K6;3.)Y]E5I-3;45S-J,I)1M>]U%JUMN_0]WKR?
M]H?X+?&KQWK^E>/_`('_`!SN?#&KZ/;/#'IEU#YFGWBNP9O-4`G)VJ,E7&%&
M`IR3A?$+]I/]H_X5>'[+5O&W[-7AN.XUCQ+IFA:+;67Q)DF6:ZO)Q"ID<Z:O
ME(I()(#D^@J7XA?M'?M"?"WP9!K?C7]G?P]!J>K>*M)T'P[867Q"DGBN)[V9
MH=\TIT]#"J-Y?17W!V^[M^:8Y=BI6MRN[LO>CKMY^>O8N6=8"'-S.2Y5=_NZ
MFBUW]WK;1;OINC)&H_\`!32]M#X=?P_\,;.9_P!W_P`)`L]PP08_U@CW-EN_
M*8_V:[;]FG]FZ'X$V.K:]XC\53>(O%OB6Z%UXC\07,>TS.,XCC'\,:DMCUSV
M`55XG4OVTOB'X636?`WB_P"!-G!X^T?6=`L8]%A\6;M.OX]6NA:V]S'=BV+H
MHD#[T>'<NT8+9R+WQ8_:R^*O[//PZ/Q-^//P(T[3K$>(M-TZ.#PWXN?59I8K
MAY%ED"M9P8>/:A5.?,W$93`)K^S,:Y**BKMV7O1UO9JVNNZU6A#S[+%"4W)I
M13<GR3M&S:?,^6R=XO1V?WHZ'X&?`OQ;\,OC;\4/B3KVHZ=-8^-M2LKC2HK.
M:1I8EA$X82AD4*3YJXVENAZ=^Z^)'PW\&?%OP9>^`?'VBQW^F7\>V:&3@J?X
M71NJNIY##D$5R7B?]ICPEH_BCX;:?H0M-4T3XBM?O;^(HM2"0VEO;:=+?"?&
MPB166+;]Y-N<G.,5R'AS]I/]I3XL^'A\4?@7^S1IFH>$)R7T67Q)XP.G:CK=
MN"0+B&`6TB0H^,IYTBEE*MA0PK..!Q4H\S22[MI=6NK6MXO3?2^QK/-\!";@
MI.4ETC&4GM&5_=3TM*.NVJ6^AN?LP_"/XX_`M+[X;>+_`!GI?B'P;:$_\(I>
MR7$HU.UBR,02H8_+9`,X(?*[<`;2%2;]GSX%>+OA/\3OB9XT\1:CITUKXS\1
MKJ&EQV4TC211`RG$H9%"M^\'"EAP>:P?"O[2W[1?Q(\0>*M-^&_[,^@7-KX4
M\2R:'>3ZO\1VM)7N8X()GQ&FGRJ%`G49#G)!KUGXF^,O^%<_#;Q#\0O[-^V?
MV#H=WJ/V/SO+\_R(7E\O?AMN[;C.#C.<'I6=?#U<.TIVN^S3^^S=OF=&$QN'
MQL7*E>RZN,H]UIS)7VZ7.$^$OP*\7>`_VCOB/\7]8U'39-,\7_8?[,@MII#/
M%Y,95O-5D"KD]-K-^%>KUY_?_%#XB^`[RTN/BMX"TRWT:\O8K4ZUH.M272V4
MDKB./[1'+!$5C+LJ^8I8`L-RJ,M5CPQ\0OB1XQNM0GT+P%H8T^QUZ[T[S[OQ
M-,DSBWG:)I/+6S91G:2%WGTS7.=9S7[8O[+.B?M/_#5M'C\BV\0Z8&F\/ZE*
MO"2$?-"Y'/EO@`]<$*V#MP:GQ5^$/C+5O">A6-M'?,(/#,.DWTFC&)[O3V$]
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M,HO])N'^;:"_ERHV/FBD"$JX'4.I^9&%`'>T5Y;X:^.?C[XC7L=O\./A[I$P
MMM$TV_U9-7\126[JUY")EBA"6TF\*A_UC;0S?*`,,5U_$_Q$^*6@^.-,\'V?
MP\\/W":Q+=#3[J7Q7/&=D*[]TB"Q;8Q4CY06`.1D]:+`=W17F6L_&/XI6%_X
MC;3/AAH]W9^$HH3K*KXFD6XF9K2.YD%NK6H1@@<JN]T\PCGRZN?$G]H7PUX`
M\(>'?&<6G7%];>(9H)4$8VM;6!C\Z>\D&#A(8?F;W*KU(HL!Z#17%?%'X@_$
M#P#;QZMI'@?1M2T^;5=.L(9;CQ)+;S&2[NX;56*+:2*%5Y@20Y)4$XSQ45[\
M1/B?;^+]/\!P_#[07U*[TFYU"8MXJG6"*.*:&,*K_8BSLQF!Y50-O4YI`=U1
M7!:S\0/BLOBRT\">'_`WAY]3;1CJ5\;SQ'.L"*)C$(HW6T+,3P=Q5<<C:W6L
MWQ)\7?%VH?#?Q=-I%I%X;\6^#[![O4M.U"W^VPE!"\L;1NK1B6*4(P63@@HX
M9`5(IV`]/HKP/QQ^TK\4/AK:ZKX?G\-)X@U.W\'07UAJEII[0V_V^3[5,4F0
M.WEQ+;0^9G<-WV:49W.BU[Y2L`4444`%?!W_``6/_8:U?XHZ)'^U%\*](:YU
MG0['R/%&G6\9,EW8IDK<(!]YXLL&&,F/!S^[P?O&BN_+<PKY9C(XBENMUW75
M?UZGE9UD^%SS+IX2OL]GU36S7I^*NNI_./7U?_P1?_Y/CTW_`+%[4?\`T4*^
MC_V]/^".]A\0M0OOB[^RG%::=K$[//J7@^5Q%:WDAR2]LYPL#D_\LVQ&<\&/
M&&\*_P""3WPX\??"K_@H3:>#?B3X.U'0]5MO#^H^;8ZG:-#(!Y8PP##YE/9A
MD$<@FOU#$YQ@LVR&O*C+7D=XO=:=OU6A^$X3AW,\@XJPE/$P]WVL+27PR]Y;
M/OY/4?=_\H?O%?\`V6U__0(:^M_^<SO_`'1C_P!NJ^2+O_E#]XK_`.RVO_Z!
M#7UO_P`YG?\`NC'_`+=5X>8_\OO^X_Y4CZ?)?^8;UPGYUSXZUW_E"QHO_97W
M_P#1,]?(-?7VMJS_`/!%O1$122?B^P``Y)\F>JG[''_!)?XY_M#7UKXL^*>G
MW?@KP>65WN;^WV7]\F<E8('Y0$=)9`%Y!428(KZ7"X["8"A7JXB:BO:3^?HM
MV_0^+QN68_-L5A:&$IN<G1I[;+3=O9+S9QG_``3U_8G\1?MB?&"&UO[26#P;
MH<T<_BG4AE=R9RMK&?\`GK)@C/\``NYCT4-^V=E96>FV<.G:?:QP6]O$L<$,
M2!5C11A5`'`````KG/@Y\&?AO\`OA_9?#+X5>&(-*TFQ7Y8HER\TA`#2ROUD
MD;`RYY.!V``ZBOS3/\ZJ9SBN9*T(Z17YM^;_`.`?MO"7#-+AO`.#?-5GK-]/
M)+R7XN[\D5SGQBTV_P!9^$7BK2-*LY+BZNO#E]#;6\2[GED:W=550.I)(`'O
M71T5X1]6>;?$SX?R>-H/AMH>I:3?2V=GXC\[5OLEQ+`]O&-&U!`S21,KQCS7
MB3((R7"GK@\7\9/@<NBR^(%\`^&=:NX;_P"&^IVKYU"[O6DG:XM2D2&61RKL
MJN0JX)V^U>^T4`>>?!Y?A]:ZY=6W@[PCXST^:2TW33>)+?5!"RJP&U6O&*A\
MMG"\D`]@:\L^&WQ1^(?P6NOB#X)LOV:?'VOZWJ'Q%UK4=#^QZ0L.G7D5Q-O@
M=KV5UBCC/&YN2HS\I(Q7TM175A\1"C&490YD[=6MO0X,9@JF)J0J4ZCA*-]4
MD]'OOI?MOZ,^%?%'[)7QJ\%^"[SX?0^&[C7-1E_9Y\3V=U>:5:L;5]8O]:AO
MC9Q.W4YDD"`X++'NP.:]5^,'['WAS2OV9-6T#X:^'?%%WK>KV>DVUW8W7C+5
M+TF-;^TEFV)<W+K$RK&QWH%90I`(Z5]*T5W3SK&3E"6UI<SM=7=[ZKM<\FGP
MMEM.G4ANI0Y%=)N*LUHVM[/<^6_VMOV8O"7@SX.Z?:_#GX?>-?$EK)\0_#]]
MXCTBT\0ZKK%Y-86MRSS>0+BY=HF\MW&8V0DE<M\JD<SXH\`>'?B9\,],\"_!
M3]GKXK^#(HOBMX7O-7F\06]Y#<BW^UD2W5M++/,R>0B%F==H0LC?3[*HI4LW
MKTZ2C*\FG>[D_+===M+E8CAO"5L1*<;1C*/+90CHM=GNKWU2W/A_XA_`?QA\
M-M'\<?#+Q%\+?&7CN*_\>^'/$G_"867VJ_U+7]%AU&'S+"68/N6YM8Q*J*K1
M[HW$BA#O:NE_X1#0_&GA/0=$^!O[-?Q(\+II/Q?\)ZMJ\7C2SN4,UO%>EI9H
MC<7$I*Q)&2^",;EX.:^NZ*IYS5E!7CK=/=V;LEJMNGRZ65D91X8P\*C<9>[9
MKX8N23<G92WWEKU?6[;9\D^/OV)O%^C?M(>$-/\`A_-(?A1J=WX@DU'2(0`?
M"]Y?:->V\K6^""EK,TBD1CB.;[NT28KI_@W\:OBO\`_A7H_P.^*'[+_CK5-=
M\):;!I%G?^#-)BO--U>"",10W$<YD18=R*I9)=A0DCV'T?1653-*F(IJG7BI
M))=T[IMW;75\UGWT>^ITTL@I8.O*KA*CIN3;V35FHJR3V2Y4X]KM;62^(="\
M/>%/"GQB^(7B?XR_L=_%_6=6U+XA2ZMHU_X8T^[DM5M3;6@128+J.*1EECER
M0&!&/F(P!]1?&%]5^(7[/_C[1="\,:FE]/X?UG3;.RN;79+=2B&:)&C7)W)(
MV"C?Q!@>,UWE%98S'?7%&\;-*V[:V2T3VV.C*\J66.?+)-2=_ABGNWJU\6_4
M\I^(FM:[\=?#_P#PK'PI\/M>M++4[J!=:UK7M.>PBL[595DD$:2[9)965=BA
M5V@ON9AMP>?\$Z+X/\/>,]6NO%G@#QV=7/C:_N[:YL;3539,C7CO#)B)O(9"
MI4G(((SNSS7NU%<!ZYX;I/P/\:>)?#JZKH>IS^&[W4/$?B&R\1K<QO'-=:)=
M:U>7"^7C[DX5PT,G\(N)"/O4Y?AWXQ\#>+=2\9^"/!DMU9^'/')ELM#B5(FO
M-+FT2Q@E^REMJEHI5;:I(#"%X\@X->X44[@>6^*-2UWXY:CH/AK0?`^M:9I>
MG^(;+5M9U;7]-:TVBTF2XC@ACDP\CO*D8+!=BH'^8DA3BV/PD\:+\'M'\3>$
M+`V/C+1K2\A6SN\Q+J5I)-(SV,V>@<$/&Y_U<@5ONEPWME%%P/G77=(O9OAU
MHWA_3?@_XST[X@Z'X.L+7PWXGTNQ$2-<_98R(9+A'*B!)<K+%<@+@.0K$@GU
M?Q1HVNW?Q.\#ZJUB\L=E'J']H7$$9\N)GMU49/8%L@9KLZ*+@>&?$;X)^,O&
MNN?$+6-)O-71I=2L9K+1#J+VVGZ]#%96XEMI=F"5EVR0E@V`<;@P!4VX/`7C
M7XS^+[[QS'<77A/2;?0ET+2-'U;PZC226TT44UTQCD(\O<YCA('_`#Z^F*]H
MHHN!XY9>'?B&/@7IWP[\0:;?7NI^&/'&A67VUK<YU"RM=8LI4O!CJ/LJAG/.
M&24$_*:E^-N@:+=_&'0]=\7>$?$^HZ7%X:O8!-X:AOF:.X:XMF57-F0P!5'.
M&XX]:]>HHN!Y'#X@M?"'Q$TGQ78>`_%TNCS>#38VBIH5Y<7$4B760DP8&1"5
MY!D/(YS6MX`A\2ZG\2M5^(OC#P3?Z:OB33[;3--TZ8)(UK9V9N)1)=E&*1O*
M]U)M0%L*J@D,6`]&HHN!&;6U8.&MHSYB!),H/F7G@^HY/'O4E%%(`HHHH`**
M**`"H)],TVZO8-2N=/@DN+4.+:X>(%X=PPVUB,KD``XZXJ>BA-H32>YXSXN_
M8'_9J\4_!'4?V>[/PG=Z-X:U/73K-S;Z5J<HD%Z0`95:8R;?NK\@&WCIUKJE
M_9T^':_M$-^T\1?'Q.WAT:*";H?9UM0Y?B/;]XGN2>G05WE%=3QN,DFG4;O?
MKWM?[[*_H<,<JRV$E*-**MRVLDK<M^7;MS.WJ<;\*?V?/@U\$?!5G\._AGX#
MM=/T?3[]KVRM)9)+GR;DC!F5YV=P^"1NSD9/K79445A4J5*LW*;;;ZO5G51H
M4</35.E%1BM$DDDEZ(****@U"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
F***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`__]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ex99-1.htm
<DESCRIPTION>PRESS RELEASE DATED JANUARY 16, 2014
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: j
    Document created using Disclosure Solutions PROFILE 2.2.2.0
    Copyright 1995 - 2014 Thomson Reuters Accelus.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" bgcolor="#ffffff" text="#000000">
<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left"><img src="nselogo3.jpg"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 12pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left">FOR IMMEDIATE RELEASE</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left">CONTACTS:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; COLOR: #000000">Investors &#8212; Scott Pond (801) 345-2657, </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; COLOR: #0063ff"><u>spond@nuskin.com</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif"><br>
</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; COLOR: #000000">Media &#8212; Kara Schneck (801) 345-2116, </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; COLOR: #0063ff"><u>kschneck@nuskin.com</u></font></div>

<div><br>
</div>

<div><br>
</div>

<div style="FONT-SIZE: 12pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">NU SKIN ISSUES STATEMENT ON CHINA BUSINESS</div>

<div><br>
</div>

<div style="MARGIN-BOTTOM: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: left">PROVO, Utah, Jan. 16, 2014 &#8211; Nu Skin Enterprises, Inc. (NYSE: NUS) today issued the following statement in regards to its China business.</div>

<div style="MARGIN-BOTTOM: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: left">"We are aware that Chinese regulators have now initiated investigations to review issues raised by recent news reports. The government regularly monitors all businesses in this rapidly growing marketplace, and as is our practice, we will continue to communicate openly with regulators to address any questions they may have.</div>

<div style="MARGIN-BOTTOM: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: left">"As part of our ongoing&#160;commitment&#160;to comply with all applicable Chinese regulations, we have initiated our own province-by-province business review and will invite relevant regulators to provide guidance. Given the substantial growth in our China salesforce over the last year, we are also taking additional steps to reinforce our training and education efforts. As we work through this evolving situation and remain focused on long-term growth, there will likely be a negative impact on China revenue, but it is too early to know whether our previous guidance will be affected.</div>

<div style="MARGIN-BOTTOM: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: left">"We remain committed to working cooperatively with the government to ensure long-term, sustainable growth in this important market. Nu Skin has an 11-year history of doing business in China. We are dedicated to operating in full compliance with all applicable regulations as interpreted and enforced by the government of China."</div>

<div style="MARGIN-BOTTOM: 10pt">&#160;</div>

<div style="MARGIN-BOTTOM: 10pt">&#160;</div>

<div style="MARGIN-BOTTOM: 10pt; TEXT-ALIGN: center">-more-</div>

<div style="MARGIN-BOTTOM: 10pt"><br>
 &#160;</div>

<div style="MARGIN-BOTTOM: 10pt">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<hr id="DSPFPageBreak" style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade="noshade">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: left">Nu Skin China Business</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: left">Jan. 16, 2014</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: left">Page 2</div>

<br>
</div>

<div style="MARGIN-BOTTOM: 10pt"><br>
</div>

<div style="MARGIN-BOTTOM: 10pt; FONT-SIZE: 12pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left">About Nu Skin Enterprises, Inc.</div>

<div style="MARGIN-BOTTOM: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: left">Nu Skin Enterprises, Inc. demonstrates its tradition of innovation through its comprehensive anti-aging product portfolio, independent business opportunity and corporate social responsibility initiatives. The company's scientific leadership in both skin care and nutrition has established Nu Skin as a premier anti-aging company. The company's anti-aging products feature the new ageLOC suite of products including the ageLOC<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> TR90&#8482; weight management and body shaping system, ageLOC<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> R<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup> nutritional supplement, and ageLOC<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Transformation daily skin care system. A global direct selling company, Nu Skin operates in 53 markets worldwide and is traded on the New York Stock Exchange under the symbol 'NUS'. More information is available at <font style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif">http://www.nuskin.com</font>.</div>

<div style="TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-WEIGHT: bold">Please Note:</font> This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended that represent the company's current expectations and beliefs. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws and include, but are not limited to, statements of management's expectations regarding government investigations in Mainland China, statements relating to the company's compliance and government relations efforts and the company's initiatives and plans in Mainland China; statements of management's expectations regarding revenue, statements of belief; and statements of assumptions underlying any of the foregoing. In some cases, you can identify these statements by forward-looking words such as "believe," "expect," "project," "anticipate," "estimate," "intend," "plan," "targets," "likely," "will," "would," "could," "may," "might," the negative of these words and other similar words.</div>

<div><br>
</div>

<div style="MARGIN-BOTTOM: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left">The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially from any forward-looking statements or views expressed herein. These risks and uncertainties include, but are not limited to, the following:</div>

<div>
<table class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; FONT-STYLE: italic; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">&#183;</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left">risk that regulatory and media scrutiny and investigations in Mainland China, and any resulting steps taken by the company, could negatively impact the company's revenue and business in this market, including the interruption of sales activities, loss of licenses, and the imposition of fines, and any other adverse actions or events; and</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div>
<table class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; FONT-STYLE: italic; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">&#183;</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left">risks associated with rapid growth in Mainland China, which could strain our ability to effectively manage our operations, and result in, among other things, product delays or shortages, operating mistakes and errors, inadequate customer service, inappropriate claims or promotions by our sales force, and governmental inquires and investigations, all of which could harm our revenue and ability to generate sustained growth and result in unanticipated expenses.</div>
</td>
</tr>
</table>
</div>

<div style="MARGIN-BOTTOM: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left">&#160;</div>

<div style="MARGIN-BOTTOM: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left">The company's financial performance and the forward-looking statements contained herein are further qualified by a detailed discussion of associated risks set forth in the documents filed by the company with the Securities and Exchange Commission. The forward-looking statements set forth the company's beliefs as of the date that such information was first provided and the company assumes no duty to update the forward-looking statements contained in this release to reflect any change except as required by law.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: ''Times New Roman'', Times, serif; TEXT-ALIGN: center"># # #</div>

<div style="MARGIN-BOTTOM: 10pt"><br>
</div>

<div><br>
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
